drugset / Trial / NCT06414902
18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal Cancer
NaSingle-groupOpen-labelTreatment
Summary
To learn if 18F-FAraG PET scans can find tumors in participants with esophageal cancer and predict a participant's response to treatment.
Timeline
- Start
- 2024-09-04
- Primary completion
- 2027-10-01
- Completion
- 2027-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ArabinoFuranosylGuanine [18F]F-AraG | Diagnostic / imaging agent | — | Intravenous |